A report for the Rural Industries Research and Development Corporation. by Dr. David B. Boyle. September 2003
|
|
- Milton Porter
- 6 years ago
- Views:
Transcription
1 NEW FOWL POX VACCINE EVALUATION Evaluation of fowl pox (FPV) strains free of reticuloendotheliosis virus as vaccines for use in Australian poultry flocks A report for the Rural Industries Research and Development Corporation by Dr. David B. Boyle September 2003 RIRDC Publication No 03/086 RIRDC Project No CSA-16A
2 2003 Rural Industries Research and Development Corporation. All rights reserved. ISBN ISSN New Fowl Pox Vaccine Evaluation Evaluation of fowl pox (FPV) strains free of reticuloendotheliosis virus (REV) as vaccines for use in Australian poultry flocks Publication No. 03/086 Project No. CSA-16A The views expressed and the conclusions reached in this publication are those of the author and not necessarily those of persons consulted. RIRDC shall not be responsible in any way whatsoever to any person who relies in whole or in part on the contents of this report. This publication is copyright. However, RIRDC encourages wide dissemination of its research, providing the Corporation is clearly acknowledged. For any other enquiries concerning reproduction, contact the Publications Manager on phone Researcher Contact Details Dr. David Boyle CSIRO Livestock Industries Australian Animal Health Laboratory Private Bag 24 GEELONG VIC 3220 Phone: Fax: david.boyle@csiro.au In submitting this report, the researcher has agreed to RIRDC publishing this material in its edited form. RIRDC Contact Details Rural Industries Research and Development Corporation Level 1, AMA House 42 Macquarie Street BARTON ACT 2600 PO Box 4776 KINGSTON ACT 2604 Phone: Fax: rirdc@rirdc.gov.au. Website: Published in September 2003 Printed on environmentally friendly paper by Canprint ii
3 Foreword Ongoing problems with recurrent fowl pox disease have been experienced in some sectors of the meat chicken breeder industry over the past half decade. The only vaccine strain available in Australia (FPV M strain) has proven ineffective in controlling the problem on certain breeder farms. Although suitable for day old vaccination, this strain has not proven effective for revaccination of broiler breeder flocks coming into production. No other fowl pox virus (FPV) vaccine strains are available in Australia. Earlier studies have shown that the previously available FPV S vaccine is contaminated with reticuloendotheliosis virus REV), with the REV provirus integrated into the FPV genome. A small RIRDC-funded project was previously conducted by this CSIRO research team to remove the REV provirus from the FPV S vaccine and two field strains. The integrated REV genome was successfully removed from FPV S vaccine strain and two field strains, FPV 59vac and 62vac, in the course of that project (RIRDC Project CSA-8A Removal of reticuloendotheliosis (REV) contamination from fowl pox (FPV) S and FPV field strains for use as enhanced fowl pox vaccines in Australia ). Preliminary in vivo testing of these strains has shown them to be free of REV contamination. The project reported on herein was aimed at undertaking vaccine efficacy, safety and adventitious agent testing prior to the conduct of a field trial for the registration of one of these candidate vaccine strains for use in Australian poultry flocks. The benefits to the industry to accrue from this work will be the availability of a new FPV vaccine strain that is more immunogenic than the currently available vaccine strains. The new vaccine strain should be suitable to boost immunity to FPV in mature age birds and thus reduce the losses in broiler breeder flocks associated with fowl pox disease. This project was funded from industry revenue, which is matched, by funds provided by the Federal Government. This research project was funded from industry revenue, which is matched by funds provided by the Federal Government. This report is a new addition to RIRDC s diverse range of over 900 research publications and forms part of our Chicken Meat R&D program, which aims to support increased sustainability and profitability in the chicken meat industry by focusing research and development on those areas that will enable the industry to become more efficient and globally competitive and that will assist in the development of good industry and product images. Most of our publications are available for viewing, downloading or purchasing online through our website: downloads at purchases at Simon Hearn Managing Director Rural Industries Research and Development Corporation iii
4 Acknowledgements CSIRO wishes to acknowledge the technical support provided by various staff members during the conduct of this project, including Mrs. Mary Ann Anderson, Mr. Tony Pye, Ms. Maria Cardoso and Mr. Matthew Rudd. Abbreviations FPV = REV = NSW = mm = SPF = GMP = CIT = fowl pox virus reticuloendotheliosis virus New South Wales millimetres specific pathogen free good manufacturing practice chick inoculation test iv
5 Contents Foreword... iii Acknowledgements...iv Abbreviations...iv List of Figures...v Executive Summary...vi 1. Introduction Objectives Methodology...2 Strain Selection for GMP Manufacture... 2 Vaccination... 2 Vaccine take... 2 Vaccine efficacy... 2 REV freedom... 2 Safety, Potency and Chick Inoculation Testing (CIT)... 2 Vaccine production... 2 Safety, potency and CIT tests Detailed Results...3 Strain Selection for GMP Manufacture... 3 Vaccine take... 3 Vaccine efficacy... 4 REV Freedom... 5 Safety, Potency and Chick Inoculation Testing... 6 Vaccine production... 6 Safety, Potency and CIT tests Discussion Implications Recommendations References...7 List of Figures Figure 1. Vaccine take as assessed by wing web thickness post vaccination... 3 Figure 2. Vaccine efficacy assessed by wing web thickness post challenge... 4 Figure 3. Antibodies to REV in vaccinated chickens at 21 days post vaccination... 5 v
6 Executive Summary This project aimed to complete the development and laboratory evaluation of a new FPV vaccine strain that is more immunogenic than the currently available vaccine strain and which should be suitable to boost immunity to FPV in mature age birds and thus reduce the losses in broiler breeder flocks associated with fowl pox disease. Vaccine efficacy, safety and adventitious agent testing was undertaken in the course of this project on reticuloendotheliosis free fowl pox strains derived from the fowl pox standard vaccine strain and two field strains. The reticuloendotheliosis free status of these strains was confirmed in this project. One strain was selected for manufacture by the commercialising partner in the project, Intervet Pty. Ltd., on the basis of vaccine take, freedom from reticuloendotheliosis virus and protection provided in laboratory based vaccination and challenge experiments. This strain meets the European Pharmacopoeia requirements for safety, potency and freedom from adventitious poultry pathogens. Intervet Pty. Ltd., in collaboration with industry, will conduct a field trial to determine suitability for registration of this strain for use by the Australian poultry industry. vi
7 1. Introduction The unique association of fowl pox virus with reticuloendothelosis virus which we have described (Hertig et.al., 1997) has not previously been documented. Our studies have shown that the FPV S strain vaccine, withdrawn from use in Australia because of suspected REV contamination, does not contain free REV but has REV provirus integrated into its genome. Unpublished studies show also that most if not all Australian fowl pox field strains similarly carry the REV provirus integrated into the FPV genome. Upon infection of chickens with the FPV S vaccine, infectious REV is produced in the chicken. The emergence of variant strains of fowl pox not protected against by existing vaccines has been documented in the United States of America (Fatunmbi and Reed, 1996). Our own studies on field isolates of fowl pox from New South Wales have documented a wide range of genotypes and phenotypes present in the field (Boyle et. al., 1996). We have no data on the efficacy of existing vaccines against these field isolates. Our previous studies on the use of fowl pox virus as a vector for vaccine antigens have established the necessary techniques for the specific deletion of the REV provirus genome from FPV S and field strains. Approximately 20 peer reviewed publications have been prepared by the author s research group in this area in the past decade. Using these techniques we now have derived strains of FPV free of REV provirus. Upon infection of chickens these strains do not lead to REV infection. One large broiler breeder operation, in particular, has experienced ongoing problems with recurrent fowl pox diseases over the past half decade. The only vaccine stain available in Australia has proven ineffective in controlling this problem. Although suitable for day old vaccination, this strain has not proven effective for revaccination of broiler breeder flocks coming into production. No other FPV vaccine strains are available in Australia. Our studies have shown that the previously available FPV S vaccine is contaminated with REV, with the REV provirus being integrated into the FPV genome. RIRDC previously funded the author s research team to conduct a small project to remove the REV provirus from the FPV S vaccine and two field strains. The integrated REV genome was successfully removed from FPV S vaccine and two field strains, FPV 59vac and 62vac, in the course of this earlier project. Preliminary in vivo testing of these strains has shown them to be free of REV contamination (RIRDC Project CSA-8A Removal of reticuloendotheliosis (REV) contamination from fowl pox (FPV) S and FPV field strains for use as enhanced fowl pox vaccines in Australia). The current project was aimed at undertaking vaccine efficacy, safety and adventitious agent testing prior to the conduct of a field trial for the registration of one of these strains for use in Australian poultry flocks. 2. Objectives The project objectives were to undertake vaccine efficacy, safety and adventitious agent testing on reticuloendotheliosis (REV) free fowl pox virus (FPV) strains derived from FPV S (Standard vaccine strain) and two field strains, FPV 59vac and FPV 62vac.These studies were conducted in collaboration with a commercial partner (Intervet Pty. Ltd.) to ensure that the results would be suitable for registration purposes and manufacture of selected strain(s) for delivery to the Australian poultry industry as new FPV vaccine(s). 1
8 3. Methodology Strain Selection for GMP Manufacture Vaccination Three REV free FPV strains derived from FPV S (FPV 79b), FPV 59vac (FPV 81b) and FPV 62vac (FPV 85a) strains were evaluated in vaccination and challenge experiments in three-week-old specific pathogen free poultry (SPF). Chickens (five to six per group) were vaccinated by wing web inoculation using industry standard bifurcated needle fowl pox vaccine applicators. Vaccination with the FPV Mild vaccine strain (Fort Dodge) (FPV M) was used for comparison with the strains for assessment of vaccine take and protective efficacy. Vaccine take Vaccine take was monitored by measuring, every two to three days, wing web thickness at the inoculation site using callipers. Vaccine efficacy The efficacy of the vaccine was determined by challenging the chickens with the NSW field isolate FPV 62vac by wing web inoculation in the wing opposite to that used for vaccination. Wing web thickness was monitored for ten to 14 days post challenge. The chickens were also examined for spread of the challenge virus from the primary challenge site. REV freedom Freedom from REV contamination was determined in the vaccination and challenge experiment. Serum samples collected at 21 days post vaccination were tested for antibodies to REV using a commercial ELISA antibody test. Safety, Potency and Chick Inoculation Testing (CIT) Vaccine production Intervet Pty. Ltd. manufactured the chosen strain under GMP conditions at their Bendigo plant. A master seed, working seed and three pilot batches of vaccine were prepared using their standard FPV vaccine production methods. FPV titre in the seeds and pilot vaccine batches was determined at CSIRO by plaque assay on chicken embryo skin cells. Safety, potency and CIT tests Safety, potency and chick inoculation test (CIT) tests were conducted as per European Pharmacopoeia, Fourth Edition September 2001 on master and working seeds and pilot vaccine lots of the fowl pox vaccine. The only significant protocol modification was that potency test chickens were challenged by wing stab inoculation rather than by feather follicle inoculation. Wing web stab inoculation allowed the measurement of responses by monitoring wing web thickness following vaccination and challenge. The safety test was conducted with the pilot batch with the highest titre. The CIT test was conducted on a pool of all five batches (two seeds and three pilots). The potency test was conduced on the pilot batch with the lowest titre of virus. 2
9 4. Detailed Results Strain Selection for GMP Manufacture Vaccine take Vaccine take as assessed by wing web thickness measurements showed that FPV 79b and FPV 85a gave a larger and more prolonged local lesion in comparison with the FPV M Vaccine and FPV 81b (Figure 1). For FPV M and FPV 81b the wing web lesion peaked by five to seven days post vaccination and was substantially resolved by ten days post vaccination. In comparison for FPV 79b and FPV 85a maximum lesion thickness occurred at seven days post vaccination and the lesion was not fully resolved until 13 to17 days post vaccination. None of the vaccinated chickens developed FPV lesions at sites other than the vaccination site. Mean Wing Web Thickness Post Vaccination mm +/- SD Unvacc FPV M FPV 79b FPV 81b FPV 85a Days Post Vaccination Figure 1. Vaccine take as assessed by wing web thickness post vaccination. 3
10 Vaccine efficacy Vaccine efficacy was assessed by challenge with a virulent NSW field strain, FPV 62vac. Wing web thickness was measured for ten days following challenge (Figure 2) and visual assessment of challenge virus take was also undertaken. All chickens vaccinated with FPV 85a were fully protected no change occurred in wing web thickness and no visible lesion developed at the challenge inoculation site. For FPV M, FPV 79b and FPV 81b, a visible lesion developed at the challenge inoculation site for three or four of the five chickens challenged. This was accompanied by a small increase in wing web thickness measured at days three to seven post challenge. Mean Wing Web Thickness Post Challenge 6 5 mm +/- SD Unvacc FPV M FPV 79b FPV 81b FPV 85a Days Post Challenge Figure 2. Vaccine efficacy assessed by wing web thickness post challenge. 4
11 REV Freedom Freedom from REV contamination of the FPV vaccine strains was confirmed, since none of the chickens vaccinated developed antibodies to REV by 21 days post vaccination. In comparison, all chickens vaccinated at the same time with the parent strains from which the vaccine strains were derived developed antibodies to REV (Figure 3). REV ELISA Antibody Response Post Vaccination Mean Antibody Titre Day 21 Post Vaccination 0 Unvacc FPV M FPV 79b FPV 81b FPV 85a FPV S FPV 59vac FPV 62vac Virus Strain Figure 3. Antibodies to REV in vaccinated chickens at 21 days post vaccination. For comparison the parent strains used for generation of the REV free FPV strains were also tested (FPV S, 59vac and 62vac). Strain FPV 85a was selected for further vaccine development on the basis of freedom from REV contamination, effective vaccine take in all chickens, satisfactory growth in cell culture and provision of the best protection when challenged with the field strain from which this vaccine was derived. 5
12 Safety, Potency and Chick Inoculation Testing Vaccine production The FPV 85a strain derived from NSW field isolate FPV 62vac was provided to Intervet Pty. Ltd. on 31/7/2001 for GMP manufacture using their standard FPV vaccine production protocols. CSIRO Microstores identification of the virus provided to Intervet is A full passage history from the time of receipt of FPV 62vac by CSIRO AAHL (21/10/1997), including the source of biological materials used during the derivation of FPV 85a, was provided to Intervet. Intervet prepared master and working seeds and three pilot vaccine lots under GMP conditions at their Bendigo plant. Samples of these seeds and pilot vaccine lots were provided to CSIRO for titration and for safety, potency and CIT testing. Safety, Potency and CIT tests Safety, potency and CIT tests were conducted at CSIRO AAHL in three to four week old SPF chickens as per European Pharmacopoeia, Fourth Edition September The only significant protocol modification was that potency test chickens were challenged by wing stab inoculation rather than by feather follicle inoculation. Wing web stab inoculation allowed the measurement of responses by monitoring wing web thickness following vaccination and challenge. Safety Test. 11/11 chickens inoculated at three to four weeks of age via wing web stab inoculation with 10 x the recommended vaccine dose of a pilot vaccine batch survived for 21 days. None of the chickens showed any signs of disease other than the localised fowl pox lesion at the primary inoculation site. Potency Test. 24/24 chickens inoculated at three to four weeks of age via wing web stab inoculation with the recommended vaccine dose of a pilot vaccine batch developed a localised fowl pox lesion at the primary inoculation site. 24/24 non-vaccinate controls showed no signs of infection. 24/24 vaccinated chickens challenged by wing web stab inoculation at 21 days post vaccination with a field strain of FPV (FPV 62vac the strain from which the vaccine was developed) were completely protected from the development of a fowl pox lesion at the inoculation site. 24/24 non-vaccinated controls similarly challenged developed a fowl pox lesion at the challenge inoculation site. CIT Test. 12 chickens were inoculated and re-inoculated with a pool of two seed stocks and three pilot vaccine lots. All chickens survived for six weeks post primary vaccination. Serum samples collected three weeks post the secondary inoculation were negative for antibodies to all poultry pathogens tested. The FPV vaccine strain based on FPV 85a (a REV free derivative of field strain FPV 62vac) was therefore shown to meet the European Pharmacopoeia, Fourth Edition September 2001 requirements for safety, potency and freedom from adventitious poultry pathogens (CIT test). 6
13 5. Discussion We have been able to identify a suitable Australian FPV candidate vaccine strain from which the REV provirus has been removed. This strain provides good protection in vaccination and challenge experiments in SPF chickens. Freedom from REV contamination has been confirmed. Master and working seeds for vaccine production have been prepared by Intervet Pty. Ltd. Three pilot vaccine batches were prepared under GMP manufacturing conditions. Safety, potency and CIT tests conducted on the master and working seeds and the pilot vaccine batches confirm that the FPV vaccine based on FPV 85a (a REV free derivative of field strain FPV 62vac) meets the European Pharmacopoeia, Fourth Edition September 2001 requirements for safety, potency and freedom from adventitious poultry pathogens (CIT test). 6. Implications The FPV candidate vaccine strain that has been developed will need to be evaluated in field trials to be conducted by Intervet Pty. Ltd. to ascertain if it is suitable for use by the Australian poultry industry for the control of fowl pox disease. Subject to the suitability of the candidate vaccine for use in control of fowl pox in Australia being demonstrated in these field trials and the vaccine subsequently being registered for use for this purpose, then the Australian poultry industries will have available an alternative, more immunogenic vaccine for the control of fowl pox in the future. 7. Recommendations That Intervet Pty. Ltd. Conduct, with the collaboration of the industry, suitable field trials to ascertain the suitability of the developed strain for use by the Australian poultry industry for the control of fowl pox disease and for national registration. 8. References Boyle, D.B. RIRDC Project CSA-8A Removal of reticuloendotheliosis (REV) contamination from fowlpox (FPV) S and FPV field strains for use as enhanced fowlpox vaccines in Australia. Final Report August Boyle, D.B., Pye, A.D. and Coupar, B.E.H. (1996) Comparison of field and vaccine strains of Australian fowlpox viruses. Archives of Virology 142 : Fatunmbi, O.O. and Reed, V.M. (1996) Evaluation of a commercial modified live virus fowl pox vaccine for the control of variant fowlpox virus infections. Avian Diseases 40: Hertig, C.H., Coupar, B.E.H., Gould, A.R. and Boyle, D.B. (1997) Field and vaccine strains of fowlpox virus carry integrated sequences from the avian retrovirus, reticuloendotheliosis virus. Virology 1997 Sep 1;235(2):
Detection of vvibdv strains and Australian variants in poultry
Detection of vvibdv strains and Australian variants in poultry A report for the Rural Industries Research and Development Corporation by J. Ignjatovic, S. Sapats and G. Gould November 2001 RIRDC Publication
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP)
European Medicines Agency Veterinary Medicines and Inspections London, 16 February 2006 Doc. Ref.EMEA/CVMP/IWP/46853/2006 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE (CVMP) REFLECTION PAPER: MINIMUM
More informationDETERMINATION OF HOST SPECIFICITY OF PIGEON POX AND FOWL POX VIRUSES ISOLATED FROM A FIELD OUTBREAK
Bulgarian Journal of Veterinary Medicine (2011), 14, No 4, 209 214 DETERMINATION OF HOST SPECIFICITY OF PIGEON POX AND FOWL POX VIRUSES ISOLATED FROM A FIELD OUTBREAK Summary A. B. SIDDIQUE 1, F. M. A.
More informationSCIENTIFIC DISCUSSION
SCIENTIFIC DISCUSSION 1. SUMMARY OF THE DOSSIER Nobilis Influenza H5N2 emulsion for injection, is an adjuvanted, inactivated vaccine against avian influenza type A, subtype H5 in chickens. Avian influenza
More informationAVIAN ENCEPHALOMYELITIS- FOWL POX-PIGEON POX VACCINE
AVIAN ENCEPHALOMYELITIS- FOWL POX-PIGEON POX VACCINE Avian Encephalomyelitis Fowl Pox Pigeon Pox Vaccine is a chicken embryo propagated, freeze-dried, vaccine for wing web administration in chickens. The
More informationImmunity and Poultry Health (3)
Understanding vaccines and vaccination programmes Protecting the health of poultry through vaccination has been an essential part of poultry production for more than 50 years. Vaccination is the final
More informationAvian Infectious Bronchitis Vaccine, Inactivated
Avian Infectious Bronchitis Vaccine, Inactivated Avian Infectious Bronchitis Vaccine, Inactivated consists of an emulsion or a suspension of one or more serotypes of avian infectious bronchitis virus which
More informationSalmonella Enteritidis Response Plan
Salmonella Enteritidis Response Plan An Approach to Salmonella Enteritidis Detection Developed on behalf of the Australian Egg Corporation Limited by Dr Peter C. Scott Version 1 June 2017 2017 Australian
More informationLaboratory tools for monitoring and understanding IBDV infection and vaccination
Laboratory tools for monitoring and understanding IBDV infection and vaccination J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands Gumboro-virus (IBDV) Avibirna-virus: segments of
More informationVACCINES FOR VETERINARY USE Vaccina ad usum veterinarium
EUROPEAN PHARMACOPOEIA 6.0 Vaccines for veterinary use out,theexpirydateforthefinallotiscalculatedfromthe date of an approved stability-indicating test or failing this fromthedateoffreeze-dryingorthedateoffillingintothe
More informationLive vaccines for three species of Eimeria
Live vaccines for three species of Eimeria A report for the Rural Industries Research and Development Corporation by Glenn Anderson and Wayne Jorgensen April 2003 RIRDC Publication No 03/ RIRDC Project
More informationmaking LT protection safer and easier
making LT protection safer and easier 1 vaccine up to 3 immunities 4 Vectormune FP-LT and. Vectormune FP-LT is a genetically engineered live fowl pox virus vaccine carrying 2 immunorelevant genes from
More informationLSD: Vaccine Quality
Standing Group of Experts on Lumpy Skin Disease in Europe under the GF-TADs umbrella Third meeting (LSD3) Istanbul, Turkey, 12-13 December 2016 LSD: Vaccine Quality LSD Experts: Dr Kris De Clercq and Dr
More informationASEAN STANDARDS FOR ANIMAL VACCINES
Adopted at the 40 th AMAF 11 October 2018 Ha Noi, Viet Nam ASEAN Cooperation in Food, Agriculture and Forestry ASEAN STANDARDS FOR ANIMAL VACCINES Third Edition Li v e s t o c k Publication Series No.2A
More informationThe development of avian influenza vaccines for emergency use
11 The development of avian influenza vaccines for emergency use T.R. Mickle, D.E. Swayne, and N. Pritchard Abstract Costly outbreaks of mildly and highly pathogenic avian influenza (AI) have occurred
More informationeconomic impact of the roslin institute - Executive Summary Executive Summary by BiGGAR Economics
ECONOMIC IMPACT OF THE ROSLIN INSTITUTE Executive Summary by BiGGAR Economics 1 executive summary ECONOMIC IMPACT OF THE ROSLIN INSTITUTE 2011/12 293 staff 142 post-graduate students 25.4 million funding
More informationSCIENTIFIC DISCUSSION EMEA/V/C/036. Intervet International B.V., Wim de Körverstraat 35, 5831 AN Boxmeer, The Netherlands. N/a
SCIENTIFIC DISCUSSION Product name: Nobilis IB 4-91 Procedure No.: EMEA/V/C/036 Applicant company : Active substances and strengths: (ATCvet code) Proposed International Non-proprietary Name: Intervet
More informationAvian encephalomyelitis (AE) Epidemic tremor. Dr./ Wafaa Abd El-ghany Assistant Professor of poultry dis., Fac. Vet. Med., Cairo Univ.
Avian encephalomyelitis (AE) Epidemic tremor Dr./ Wafaa Abd El-ghany Assistant Professor of poultry dis., Fac. Vet. Med., Cairo Univ. Definition Avian encephalomyelitis (AE) is a viral infection affecting
More informationDEVELOPMENT OF SALMONELLA VACCINATION STRATEGIES FOR THE AUSTRALIAN POULTRY INDUSTRY
DEVELOPMENT OF SALMONELLA VACCINATION STRATEGIES FOR THE AUSTRALIAN POULTRY INDUSTRY Clive Jackson 1 and Greg Underwood 2 1 Biological Technology Transfer Pty Ltd, 2 Victory Avenue, Camden NSW 2570 2 BIOPROPERTIES
More informationExcretion of bluetongue virus in cattle semen: a feature of laboratory-adapted virus
Vet. Ital., 40 (4), 497-501 Bluetongue virus and disease Excretion of bluetongue virus in cattle semen: a feature of laboratory-adapted virus P.D. Kirkland (1), L.F. Melville (2), N.T. Hunt (2), C.F. Williams
More informationFMD VACCINE AND VACCINATION. Ahmad Al-Majali Dean, Faculty of Vet Medicine JUST Jordan
FMD VACCINE AND VACCINATION Ahmad Al-Majali Dean, Faculty of Vet Medicine JUST Jordan General Considerations on FMD vaccination The currently used FMD vaccines are killed virus preparations that are pure,
More informationGuideline on quality aspects on the isolation of candidate influenza vaccine viruses in cell culture
11 July 2011 EMA/CHMP/BWP/368186/2011 Committee for Human Medicinal Products (CHMP) Guideline on quality aspects on the isolation of candidate influenza vaccine viruses in Draft Agreed by Biologics Working
More informationVETERINARY SERVICES POLICY STATEMENT
ASTRAL OPERATIONS LTD VETERINARY SERVICES POLICY STATEMENT I, the undersigned, CEO of Astral Operations Ltd, am committed to a policy of continuous improvement of poultry health and food safety and will
More informationAmerican Association of Avian Pathologists AviServe LLC Avian Biosciences Center AviServe LLC
The American Association of Avian Pathologists is a proud sponsor of AviServe LLC The Avian Biosciences Center at the University of Delaware is a proud sponsor of AviServe LLC is a proud sponsor of Cobb-Vantress,
More informationEvaluation of Biosecurity Status in Commercial Broiler Farms in Sri Lanka
International Journal of Scientific and Research Publications, Volume 7, Issue 4, April 217 114 ISSN 225-3153 Evaluation of Biosecurity Status in Commercial Broiler Farms in Sri Lanka W.M.J.B. Wijesinghe
More informationFMD diagnostics: current developments and application in the context of FMD control in endemic countries Wilna Vosloo
FMD diagnostics: current developments and application in the context of FMD control in endemic countries Wilna Vosloo CSIRO Livestock Industries, Australian Animal Health Laboratory (AAHL), Geelong, Australia
More informationMethods for Control of Fowl Pox
Methods for Control of Fowl Pox Item Type text; Book Authors Pistor, William J. Publisher College of Agriculture, University of Arizona (Tucson, AZ) Download date 06/06/2018 22:45:33 Link to Item http://hdl.handle.net/10150/312132
More informationPUBLICLY AVAILABLE ASSESSMENT REPORT FOR A VETERINARY MEDICINAL PRODUCT
PAUL-EHRLICH-INSTITUT Bundesamt für Sera und Impfstoffe Federal Agency for Sera and Vaccines Paul-Ehrlich-Strasse 51-59 63225 Langen Germany MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT
More informationAnnex 4. Recommendations to assure the quality, safety and efficacy of influenza vaccines (human, live attenuated) for intranasal administration
Annex 4 Recommendations to assure the quality, safety and efficacy of influenza vaccines (human, live attenuated) for intranasal administration Introduction 156 General considerations 156 Part A. Manufacturing
More informationCampylobacter work at the UK Veterinary Laboratories Agency
Campylobacter work at the UK Veterinary Laboratories Agency Monique Toszeghy CRL Workshop for Campylobacter SVA, Uppsala, Sweden 24 th October 2006 History of VLA 1894 - a forerunner to the Central Veterinary
More informationThis paper is in two Sections (A and B) and instructions relating to the number of questions to be answered are given at the head of each Section.
TUESDAY 28 MARCH 2000 PAPER I (3 hours) This paper is in two Sections (A and B) and instructions relating to the number of questions to be answered are given at the head of each Section. SECTION A Two
More informationStudies on Thermostability of Newcastle Disease Viruses (Local Isolates) for Preparation of Vaccine
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 7 Number 01 (2018) Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/10.20546/ijcmas.2018.701.060
More information! " ## $%& &'( ) Page 1 of 7
! " ## $%& &'( ) *+, -+.//0 Page 1 of 7 Introduction This report reflects the discussion and conclusions of a group of experts on regulatory aspects of vaccines from national and international regulatory
More informationHPAI virus evolution and vaccination in Indonesia
OFFLU avian influenza virus characterisation meeting 29 30 March 2017 FAO Headquarters, Rome, Italy HPAI virus evolution and vaccination in Indonesia Ernes Andesfha 1 Hendra Wibawa 2,3 1 National Veterinary
More informationMaximising the benefits of Serological Monitoring and Reporting
Maximising the benefits of Serological Monitoring and Reporting AviAfrica, 21-06-2017, Johannesburg Luuk Stooker, DVM Senior Product Manager BioChek Forecast on food Source: Rabobank Forecast on meat consumption
More informationANSES. Agence Nationale du Médicament Vétérinaire (National Agency for Veterinary Drugs) (Reference Member State) BP FOUGERES CEDEX FRANCE
ANSES Agence Nationale du Médicament Vétérinaire (National Agency for Veterinary Drugs) (Reference Member State) BP 90203 35302 FOUGERES CEDEX FRANCE DECENTRALISED PROCEDURE PUBLICLY AVAILABLE ASSESSMENT
More informationAgencia Española de Medicamentos y Productos Sanitarios C/Campezo 1, Edificio Madrid España (Reference Member State)
DEPARTAMENTO DE MEDICAMENTOS VETERINARIOS Medicamentos y Productos C/Campezo 1, Edificio 8 28022 Madrid España (Reference Member State) MUTUAL RECOGNITION PROCEDURE PUBLICLY AVAILABLE ASSESSMENT REPORT
More informationDetection of reticuloendotheliosis virus as a contaminant of fowl pox vaccines
Detection of reticuloendotheliosis virus as a contaminant of fowl pox vaccines A. M. Awad,* 1 H. S. Abd El-Hamid, A. A. Abou Rawash,* and H. H. Ibrahim * Department of Avian and Aquatic Animal Medicine,
More informationWORLD OSTRICH ASSOCIATION UNDERSTANDING AND CONTROLING AVIAN INFLUENZA RISKS IN OSTRICH
UNDERSTANDING AND CONTROLING AVIAN INFLUENZA RISKS IN OSTRICH Introduction There are many good web sites containing information on Avian Influenza and offering guidelines on measures to be taken to protect
More informationGood Things Foundation Australia
Good Things Foundation Australia Our impact in the first year July 2018 www.goodthingsfoundation.org.au Good Things Foundation Australia: Our impact in the first year (July 2018) 2 A world where everyone
More informationUnit C: Poultry Management. Lesson 3: Poultry Health Management
Unit C: Poultry Management Lesson 3: Poultry Health Management 1 1 Terms All-in, all-out Intranasal vaccination Intraocular vaccination Wing web vaccination 2 2 3 I. Whether a poultry flock is housed inside
More informationSuggestions to prevent / control Respiratory Disease Complex in poultry
Suggestions to prevent / control Respiratory Disease Complex in poultry Dr. J. L. Vegad Adviser Phoenix Group 201/15, Gorakhpur, Jabalpur - 482001 Introduction Today, respiratory disease complex has emerged
More information(From the Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, New Jersey)
THE YIELD OF RABIES VIRUS IN THE CHICK EMBRYO BY BJORN SIGURDSSON, M.D.* (From the Department of Animal and Plant Pathology of The Rockefeller Institute for Medical Research, Princeton, New Jersey) (Received
More informationCOMMISSION REGULATION (EU)
23.10.2010 Official Journal of the European Union L 279/3 REGULATIONS COMMISSION REGULATION (EU) No 955/2010 of 22 October 2010 amending Regulation (EC) No 798/2008 as regards the use of vaccines against
More informationFrequently Asked Questions About Bird Flu
Frequently Asked Questions About Bird Flu Q1: What is Bird flu or Avian flu? A: It is a form of infection caused by a virus that affects birds (fowls, ducks, etc) and leads to their death. The new virus
More informationNewcastle disease and Newcastle disease vaccination in village poultry. A training manual
Newcastle disease and Newcastle disease vaccination in village poultry A training manual National Rural Poultry Centre PO Box 81 Likuni Malawi http://www.ruralpoultrymalawi.org Acknowledgements and Introduction
More informationCHARACTERISATION OF INFECTIOUS BURSAL DISEASE VIRUS AND DETERMINATION OF POSSIBLE VACCINE STRAIN(S) IN KENYA
CHARACTERISATION OF INFECTIOUS BURSAL DISEASE VIRUS AND DETERMINATION OF POSSIBLE VACCINE STRAIN(S) IN KENYA Investigator: Dr. Mutinda, W.U (BVM, MSc.) Supervisors: Prof. P.N Nyaga, BVM, MSc, PhD Prof.
More informationRegulation of FMD vaccines within the European Union
Introduction Regulation of FMD vaccines within the European Union K De Clercq 1 and D K J Mackay 2 Appendix 36 The EUFMD European Pharmacopoeia Working Group made a proposal for revision of the FMD vaccine
More informationG. W. WOOD J. C. MUSKETT and D. H. THORNTON MAFF, Central Veterinary Laboratory, New Haw, Weybridge, Surrey, U.K.
J. Comp. Path. 1986 vol. 96 OBSERVATIONS ON THE ABILITY OF AVIAN REOVIRUS VACCINMATION OF HENS TO PROTECT THEIR PROGENY AGAINST THE EFFECTS OF CHALLENGE WITH HOMOLOGOUS AND HETEROLOGOUS STRAINS By G. W.
More informationModule 1: Overview of the National Poultry Improvement Plan
Module 1: Overview of the National Poultry Improvement Plan What You Will Learn in This Module: When you have completed this module, you should: know the basic concepts of the National Poultry Improvement
More informationAvian leukosis virus sub-group J (ALV-J)
Avian leukosis virus sub-group J (ALV-J) Developing laboratory technologies for diagnosis in Australia A report for the Rural Industries Research and Development Corporation by T. Bagust, S. Fenton and
More informationPosition Description Ovarian Cancer Australia Support Coordinator, Support Programs
Position Description Ovarian Cancer Australia Support, Position Purpose The Support, is one of three roles responsible for the further development, coordination and implementation of Ovarian Cancer Australia
More informationIMPORT HEALTH STANDARD FOR THE IMPORTATION OF CHICKEN HATCHING EGGS INTO NEW ZEALAND FROM AUSTRALIA
IMPORT HEALTH STANDARD FOR THE IMPORTATION OF CHICKEN HATCHING EGGS INTO NEW ZEALAND FROM AUSTRALIA Issued pursuant to Section 22 of the Biosecurity Act 1993 Dated: 4 October 2005 USER GUIDE The information
More informationOIE Situation Report for Avian Influenza
OIE Situation Report for Avian Influenza Latest update: 25/01/2018 The epidemiology of avian influenza is complex. The virus constantly evolves and the behavior of each new subtype (and strains within
More informationInfectious Bursal Disease, Immunosuppression and the role of VAXXITEK HVT+ IBD
Research note Infectious Bursal Disease, Immunosuppression and the role of VAXXITEK HVT+ IBD Grogan K. 1 1 Poultry Chicken Scratch, LLC, 30019 Dacula GA United States of America [from Hoerr F.J., 2010,
More informationBeurteilungsbericht zur Veröffentlichung. (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Poulvac IB Primer
Beurteilungsbericht zur Veröffentlichung (gemäß 31 Abs. 2 Tierimpfstoff-Verordnung) Zulassungsdatum: 06.03.2000 Zulassungsnummer: 167a/88 Datum der Erstellung des öffentlichen Beurteilungsberichts: 15.05.2013
More informationOIE Situation Report for Highly Pathogenic Avian Influenza
OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 30/06/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with
More informationOIE Reference Laboratory Reports Activities
OIE Reference Laboratory Reports Activities Activities in 2016 This report has been submitted : 2017-01-31 14:46:00 Name of disease (or topic) for which you are a designated OIE Reference Laboratory: Newcastle
More informationThe Palliative Care Clinical Studies Collaborative (PaCCSC) is a research infrastructure that consists of a Coordinating Agency, Flinders University
The Palliative Care Clinical Studies Collaborative (PaCCSC) is a research infrastructure that consists of a Coordinating Agency, Flinders University of South Australia, a committee structure including
More informationPublic health relevant virological features of Influenza A(H7N9) causing human infection in China
Public health relevant virological features of Influenza A(H7N9) causing human infection in China Address requests about publications of the WHO Regional Office for Europe to: Publications WHO Regional
More informationGumboro Disease: where are we with IBDV epidemiology. J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands
Gumboro Disease: where are we with IBDV epidemiology J.J. (Sjaak) de Wit, DVM, PhD, dipl ECPVS GD Deventer, The Netherlands Gumboro-virus (IBDV) Avibirna-virus: 2 segments of dsrna Non enveloped virus
More informationAviagenBrief. Marek s Disease Control in Broiler Breeders
AviagenBrief January 2018 Marek s Disease Control in Broiler Breeders Author: A. Gregorio Rosales DVM, MS, PhD, DACPV - Poultry Health Consultant Introduction Marek s Disease Virus (MDV), a highly infectious
More informationVACCINES FOR VETERINARY USE Vaccina ad usum veterinarium
Vaccines for veterinary use EUROPEAN PHARMACOPOEIA 5.0 Water (2.5.12): maximum 3.0 per cent m/m for freeze-dried vaccines, unless otherwise stated. STORAGE Store protected from light. Unless otherwise
More informationOIE Situation Report for Highly Pathogenic Avian Influenza
OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 28/02/2018 The epidemiology of avian influenza is complex. The virus constantly evolves and the behavior of each new subtype (and
More informationEpidemiology of Newcastle Disease. By Dr. Jonathan Amakye Anim & Dr. John Tsitsiwu
Epidemiology of Newcastle Disease By Dr. Jonathan Amakye Anim & Dr. John Tsitsiwu Definition The current OIE definition (OIE, 2000a) is: Newcastle disease is defined as an infection of birds caused by
More informationAVIAN VIRAL TUMORS I. MAREK'S DISEASE
DEFINITION The several viral neoplastic diseases of chickens and turkeys, although previously considered a "complex", are actually distinct disease entities. In some cases a single tumor virus strain can
More informationOIE Situation Report for Highly Pathogenic Avian Influenza
OIE Situation Report for Highly Pathogenic Avian Influenza Latest update: 31/05/2018 The epidemiology of avian influenza (AI) is complex. The AI virus constantly evolves by mutation and re-assortment with
More informationAn outbreak of a respiratory infection of multi-agents occurred in poultry flocks in Tripoli, Libya
An outbreak of a respiratory infection of multi-agents occurred in poultry flocks in Tripoli, Libya S.O. Al-GARIB*, A. A. ASHEG, A. KAMMON and M.A. HAMID Department of Poultry Disease, Faculty of Veterinary
More informationEUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL. Unit G5 - Veterinary Programmes
EUROPEAN COMMISSION HEALTH & CONSUMERS DIRECTORATE-GENERAL Unit G5 - Veterinary Programmes SANCO/10778/2012 Programmes for the eradication, control and monitoring of certain animal diseases and zoonoses
More informationSurveillance and control programmes for terrestrial and aquatic animals in Norway
Surveillance and control programmes for terrestrial and aquatic animals in Norway Annual Reports 2011 The surveillance and control programme for infectious laryngotracheitis (ILT) and avian rhinotracheitis
More informationHighly Pathogenic Avian Influenza:
United States Department of Agriculture Animal and Plant Health Inspection Service Program Aid No. 1704 Highly Pathogenic Avian Influenza: A Threat to U.S. Poultry A Threat to U.S. Poultry Worldwide, there
More informationVaccines of today and products needed for the short-, intermediate- and longterm. OIE/FAO OFFLU Conference Beijing China December 4-6, 2013
Vaccines of today and products needed for the short-, intermediate- and longterm XU, Wei-Cheng OIE/FAO OFFLU Conference Beijing China December 4-6, 2013 1 Influenza A reservoir & transmission H3N8, (H5N1)
More informationAnnex 3 Recommendations for the production and control of influenza vaccine (inactivated)
World Health Organization WHO Technical Report Series, No. 927, 2005 Annex 3 Recommendations for the production and control of influenza vaccine (inactivated) Recommendations published by WHO are intended
More informationVICAL INC FORM 8-K. (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06
VICAL INC FORM 8-K (Current report filing) Filed 11/02/06 for the Period Ending 11/02/06 Address 10390 PACIFIC CENTER COURT. SAN DIEGO, CA 92121-4340 Telephone 858-646-1100 CIK 0000819050 Symbol VICL SIC
More informationAnnex 5. Generic protocol for the calibration of seasonal and pandemic influenza antigen working reagents by WHO essential regulatory laboratories
Annex 5 Generic protocol for the calibration of seasonal and pandemic influenza antigen working reagents by WHO essential regulatory laboratories Abbreviations 262 1. Introduction 262 2. Essential regulatory
More informationINCLUSION BODY HEPATITIS AND HYDROPERICARDIUM SYNDROME (ADENOVIRUS INFECTIONS)
INCLUSION BODY HEPATITIS AND HYDROPERICARDIUM SYNDROME (ADENOVIRUS INFECTIONS) AVIAN ADENOVIRUSES (CHICKEN ADENOVIRUSES, FADV) Adenoviruses are common in poultry. Many replicate in healthy birds without
More informationWORLD HEALTH ORGANIZATION. Smallpox eradication: destruction of Variola virus stocks
WORLD HEALTH ORGANIZATION EXECUTIVE BOARD EB111/5 111th Session 23 December 2002 Provisional agenda item 5.3 Smallpox eradication: destruction of Variola virus stocks Report by the Secretariat 1. The WHO
More informationEconomic Evaluation of Investment in the Chicken Meat R&D Program. RIRDC Publication No. 09/144. RIRDCInnovation for rural Australia
Economic Evaluation of Investment in the Chicken Meat R&D Program RIRDC Publication No. 09/144 RIRDCInnovation for rural Australia Economic Evaluation of Investment in the Chicken Meat R&D Program by
More informationPRESS RELEASE. Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between
Libourne, May 29 th, 2013: The signature of a scientific collaboration protocol about avian influenza vaccines between Dr. Marc Prikazsky, Chairman and Chief Executive Officer and Prof. Ren Tao, Vice-Dean
More informationInvestigations of Avian Leukosis Virus Subgroup J and Reticuloendotheliosis Virus Infections in Broiler Breeders in China
Investigations of Avian Leukosis Virus Subgroup J and Reticuloendotheliosis Virus Infections in Broiler Breeders in China Cheng, Z.,* Zhang, H., Wang G., Liu, Q., Liu, J., Guo, H. and Zhou E. College of
More informationOverseas Market Access Requirements Notification - Animal Products Act 1999 MAF Biosecurity New Zealand
Overseas Market Access Requirements Notification - Animal Products Act 1999 MAF Biosecurity New Zealand Ref: AE-CA 19L Date: 19 May 2010 OMAR B BIRAVIEC.CA 19.05.10 COMMERCIAL BIRDS TO CANADA (ORDER PSITTACIFORMES:
More informationAdvances in Marek s Disease Vaccine Development:
Advances in Marek s Disease Vaccine Development: Michel Bublot, DVM, PhD - Merial R&D Asian Avian Forum 2016, Tokyo, July 12-13 Marek s Disease Control Good flock management Cleaning, disinfection Adequate
More informationCeva HAND book of poultry diseases
IVAN DINEV & CEVA Volume 1 Ceva HAND book of poultry diseases GUMBORO CHICKEN ANaEMIA REOVIRUS MAREK RUNTING-STUNTING SYNDROME NEWCASTLe DISEASE AVIAN INFLUENZA INFECTIOUS BRONCHITIS LARyNGOTRACHEITIS
More informationThe Veterinary Biological Industry and the Production of Human Pandemic Influenza Vaccines in Mexico
The Veterinary Biological Industry and the Production of Human Pandemic Influenza Vaccines in Mexico Bernardo Lozano, DVM. Laboratorio Avi-Mex, SA de CV WHO-FAO-OIE Consultation Seminar Geneva, Switzerland
More informationMonitoring for Mycoplasma
Monitoring for Mycoplasma in vaccinated and non-vaccinated Poultry flocks Dr. Bart van Leerdam, PhD Prevention and Control Tactics of Mycoplasma spp. in Poultry 1. Maintaining flocks free of Mycoplasma
More informationEFFICACY OF AVIAN INFLUENZA VIRUS LOCALLY MANUFACTURED AND IMPORTED VACCINES ABSTRACT
Shaukat et al., The Journal of Animal & Plant Sciences, 26(3): 2016, Page: J. 653-657 Anim. Plant Sci. 26(3):2016 ISSN: 1018-7081 EFFICACY OF AVIAN INFLUENZA VIRUS LOCALLY MANUFACTURED AND IMPORTED VACCINES
More informationDiagnostic Considerations for Marek s Disease. Frederic J. Hoerr, DVM, PhD AMEVEA - Argentina Colon, Entre Rios May 15, 2013
Diagnostic Considerations for Marek s Disease Frederic J. Hoerr, DVM, PhD AMEVEA - Argentina Colon, Entre Rios May 15, 2013 Control of Marek s Disease Accurate diagnosis Apply appropriate procedures to
More informationAvian Flu Update. Dr. Sheila E. Purdum Extension Poultry Specialist Professor, Animal Science, UNL
Avian Flu Update Dr. Sheila E. Purdum Extension Poultry Specialist Professor, Animal Science, UNL Flu virsus multiple species HPAI H5N2 Largest loss of livestock due to a Foreign Animal Disease in the
More informationTHE PROPAGATION OF A VIRULENT GOAT PLEUROPNEUMONIA-LIKE ORGANISM IN THE CHICK EMBRYO
THE PROPAGATION OF A VIRULENT GOAT PLEUROPNEUMONIA-LIKE ORGANISM IN THE CHICK EMBRYO RICHARD YAMAMOTO, HENRY E. ADLER, AND DONALD R. CORDY School of Veterinary Medicine, University of California, Davis,
More informationESSENTIAL PROTECTION
ESSENTIAL PROTECTION for better life BROILER ND K VITABRON L VITAPEST L NEW L Supported by C H I C K P R O G R A M CONVENTIONAL vaccine range against Newcastle Disease CEVA HATCHERY I MMUNIZATION CONTROL
More informationN.M.T.S. Disanayaka 1, M.A.J.P. Munasinghe 1, R.M.A.S. Bandara 1, L.A.N. Liyanage 1 and P.D.C. Dissanayake 2
Sabaragamuwa University Journal Volume 14 Number 1; May 2015, pp 25-31 ISSN 1391-3166; eissn 2386-2041 DOI : http://dx.doi.org/10.4038/suslj.v14i1.7689 Meat Yield of the Strains Cobb 500, Hubbard Classic,
More informationDRAFT UGANDA STANDARD
DRAFT UGANDA STANDARD DUS 1677 First Edition 217 Poultry feed premix Specification Reference number DUS 1677: 217 UNBS 217 DUS 1677: 217 Compliance with this standard does not, of itself confer immunity
More informationAustralian Sonographer Accreditation Registry (ASAR) Policy & Procedure 9 - Annual Reporting Requirements for Accredited Sonography Courses
Sonography 1. Preamble ASAR s objective is to promote high standards of medical sonography in Australia which includes setting uniform, minimum standards of sonographer education by assessing and accrediting
More informationThe surveillance and control programme
Annual Reports 2010 Surveillance and control programmes for terrestrial and aquatic animals in Norway The surveillance and control programme for infectious laryngotracheitis (ILT) and avian rhinotracheitis
More informationOIE Regional Workshop on Enhancing Influenza Viruses National Surveillance Systems, Tokyo, August 2014
OIE Regional Workshop on Enhancing Influenza Viruses National Surveillance Systems, Tokyo, 26-28 August 2014 Animal population Birds Million Animal Million Chicken 249 Cattle 23.34 Duck 47.2 Buffalo 1.45
More informationThe surveillance and control programme
Annual Reports 2008 The surveillance and control programme for infectious laryngotracheitis (ILT) and avian rhinotracheitis (ART) in poultry flocks in Norway Bruce David Jorun Tharaldsen Chiek Er Editor
More informationOFFLU Technical Meeting Coordinating world-wide surveillance for influenza in swine OIE Paris, 6-7 April 2011
OFFLU Technical Meeting Coordinating world-wide surveillance for influenza in swine OIE Paris, 6-7 April 2011 Frank Wong CSIRO Australian Animal Health Laboratory, Geelong, Australia OIE Reference Laboratory
More informationThe Influence of Climate Change on Insect. Director Australian Animal Health Laboratory, Geelong
The Influence of Climate Change on Insect Borne Diseases (1) Professor Martyn Jeggo Professor Martyn Jeggo Director Australian Animal Health Laboratory, Geelong The problem the risk of infectious disease
More informationDepartment of Animal and Poultry Sciences October 16, Avian Leukosis Virus Subgroup J. Héctor L. Santiago ABSTRACT
Department of Animal and Poultry Sciences October 16, 2000 Avian Leukosis Virus Subgroup J Héctor L. Santiago ABSTRACT The avian leukosis viruses (ALV) are a class of retroviruses belonging to the avian
More informationQuestions and answers relating to finding of DNA fragments of a porcine circovirus in Rotarix vaccine
21 April 2010 Questions and answers relating to finding of DNA fragments of a porcine circovirus in Rotarix vaccine What is the issue? A United States academic research team discovered the presence of
More information